NYSE:RMED

Ra Medical Systems (RMED) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.54
$1.10
52-Week Range
N/A
Volume
77,500 shs
Average Volume
197,480 shs
Market Capitalization
$3.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RMED stock logo

About Ra Medical Systems Stock (NYSE:RMED)

Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.

RMED Stock News Headlines

Ra Medical Systems Inc.
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Catheter Precision Inc (VTAK)
VTAK Catheter Precision, Inc.
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Ra Medical Systems Announces First Quarter Results
Ra Medical Systems Announces Delayed 10-Q Filing
See More Headlines
Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-26,860,000.00
Pretax Margin
-97,518.88%

Debt

Sales & Book Value

Annual Sales
$10,000.00
Book Value
$4.29 per share

Miscellaneous

Free Float
4,368,000
Market Cap
$3.19 million
Optionable
Not Optionable
Beta
-0.03
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. David A. Jenkins (Age 65)
    Exec. Chairman & Interim CEO
  • Mr. Steven K. Passey CPA (Age 61)
    CFO & Sec.

RMED Stock Analysis - Frequently Asked Questions

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc (NYSE:RMED) issued its quarterly earnings data on Monday, November, 15th. The company reported ($57.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($39.50) by $18.00. The company earned $0.01 million during the quarter, compared to analyst estimates of $0.70 million.

When did Ra Medical Systems' stock split?

Ra Medical Systems's stock reverse split on the morning of Monday, October 3rd 2022. The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Ra Medical Systems own?
When did Ra Medical Systems IPO?

Ra Medical Systems (RMED) raised $50 million in an initial public offering on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

This page (NYSE:RMED) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners